Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy. Read more about Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy.
Equivalence of MammaPrint array types in clinical trials and diagnostics. Read more about Equivalence of MammaPrint array types in clinical trials and diagnostics.
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies. Read more about A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.
Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers. Read more about Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers.
Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin. Read more about Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin.
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer. Read more about Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index. Read more about FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer. Read more about Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer.
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Read more about A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial). Read more about Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).
